The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?
J Eur Acad Dermatol Venereol
.
2021 Oct;35(10):e645-e647.
doi: 10.1111/jdv.17472.
Epub 2021 Jul 13.
Authors
G Damiani
1
2
3
,
A Pacifico
4
,
F Pelloni
5
,
M Iorizzo
5
6
Affiliations
1
Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
2
Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
3
PhD Degree Program in Pharmacological Sciences, Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
4
Clinical Dermatology Department, IRCCS S. Gallicano Dermatological Institute, Rome, Italy.
5
Private Dermatology Practice, Lugano, Switzerland.
6
Private Dermatology Practice, Bellinzona, Switzerland.
PMID:
34169578
PMCID:
PMC8447358
DOI:
10.1111/jdv.17472
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Pemphigoid, Bullous* / chemically induced
Pemphigus*
SARS-CoV-2
Substances
COVID-19 Vaccines